Skip to main content
SpringerLink
Log in

Stock market behavior of pharmaceutical industry in Iran and macroeconomic factors

  • Published:
Economic Change and Restructuring Aims and scope Submit manuscript

Abstract

This paper is the first attempt to evaluate the behavior of Iran’s pharmaceutical industry in light of challenges and variations. The pharmaceutical industry can be examined from two dimensions, namely, supply and demand. With respect to the demand side, the aging population, growing urbanization, and people’s changing preferences have been identified as the major issues shaping this demand in Iran in recent years. Regarding the supply as the main focus of this paper, we examine the effect of the most important macroeconomic variables such as inflation rate of health care, oil price shocks and money growth in the pharmaceutical industry. We investigate the influencing factors through impulse response analysis and variance decomposition analysis by collecting monthly data from 2005:1 to 2016:3. The results of this study demonstrate that pharmaceutical price has increased recently, and widespread changes have occurred in the Iranian’s pharmaceutical industry. Moreover, our findings indicate that the money growth and inflation rate of health care are the most influential factors in the pharmaceutical industry in Iran, during the period of study.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Fig. 1
Fig. 2
Fig. 3
Fig. 4
Fig. 5

Similar content being viewed by others

References

  • Apergis N, Miller SM (2009) Do structural oil-market shocks affect stock prices? Energy Economics 31(4):569–575

    Article  Google Scholar 

  • Bardey D, Bommier A, Jullien B (2010) Retail price regulation and innovation: reference pricing in the pharmaceutical industry. J Health Econ 29(2):303–316

    Article  Google Scholar 

  • Bekaert G, Hoerova M, Duca ML (2013) Risk, uncertainty and monetary policy. J Monet Econ 60(7):771–788

    Article  Google Scholar 

  • Benderly J, Zwick B (1985) Inflation, real balances, output, and real stock returns. Am Econ Rev 75(5):1115–1123

    Google Scholar 

  • Bernanke BS, Kuttner KN (2005) What explains the stock market’s reaction to Federal Reserve policy? J Financ 60(3):1221–1257

    Article  Google Scholar 

  • Bhanja N, Dar AB, Tiwari AK (2012) Are stock prices hedge against inflation? A revisit over time and frequencies in India. Cent Eur J Econ Model Econ 4(3):199–213

    Google Scholar 

  • Bloom DE, Canning D, Sevilla J (2004) The effect of health on economic growth: a production function approach. World Dev 32(1):1–13

    Article  Google Scholar 

  • Bomfim AN (2003) Pre-announcement effects, news effects, and volatility: monetary policy and the stock market. J Bank Financ 27(1):133–151

    Article  Google Scholar 

  • Bouakez H, Essid B, Normandin M (2013) Stock returns and monetary policy: are there any ties? J Macroecon 36:33–50

    Article  Google Scholar 

  • Boudoukh J, Richardson M (1993) Stock returns and inflation: a long-horizon perspective. Am Econ Rev 83(5):1346–1355

    Google Scholar 

  • Bouri E (2015) Return and volatility linkages between oil prices and the Lebanese stock market in crisis periods. Energy 89:365–371

    Article  Google Scholar 

  • Brooks C (2014) Introductory econometrics for finance. Cambridge University Press, Cambridge

    Book  Google Scholar 

  • Chen SS (2007) Does monetary policy have asymmetric effects on stock returns? J Money Credit Bank 39(2–3):667–688

    Article  Google Scholar 

  • Chuliá H, Martens M, van Dijk D (2010) Asymmetric effects of federal funds target rate changes on S&P100 stock returns, volatilities and correlations. J Bank Financ 34(4):834–839

    Article  Google Scholar 

  • Chun N, Park M (2013) The impact of health insurance mandates on drug innovation: evidence from the United States. Eur J Health Econ 14(2):323–344

    Article  Google Scholar 

  • Ciner C (2001) Energy shocks and financial markets: nonlinear linkages. Stud Nonlinear Dyn Econom 5(3):203–212

    Article  Google Scholar 

  • Comanor WS, Scherer FM (2013) Mergers and innovation in the pharmaceutical industry. J Health Econ 32(1):106–113

    Article  Google Scholar 

  • Crowder WJ (2006) The interaction of monetary policy and stock returns. J Financ Res 29(4):523–535

    Article  Google Scholar 

  • Cunado J, de Gracia FP (2014) Oil price shocks and stock market returns: evidence for some European countries. Energy Econ 42:365–377

    Article  Google Scholar 

  • Degiannakis S, Filis G, Kizys R (2014) The effects of oil price shocks on stock market volatility: evidence from European data. Energy J 35(1):35–56

    Article  Google Scholar 

  • Dierks RML, Bruyère O, Reginster JY, Richy FF (2016) Macro-economic factors influencing the architectural business model shift in the pharmaceutical industry. Expert Rev Pharmacoecon Outcomes Res 16(5):571–578

    Article  Google Scholar 

  • DiMasi JA, Grabowski HG, Hansen RW (2016) Innovation in the pharmaceutical industry: new estimates of R&D costs. J Health Econ 47:20–33

    Article  Google Scholar 

  • Durai SRS, Bhaduri SN (2009) Stock prices, inflation and output: evidence from wavelet analysis. Econ Model 26(5):1089–1092

    Article  Google Scholar 

  • Elian MI, Kisswani KM (2017) Oil price changes and stock market returns: cointegration evidence from emerging market. Econ Change Restruct. https://doi.org/10.1007/s10644-016-9199-5

    Article  Google Scholar 

  • Elyasiani E, Mansur I, Odusami B (2011) Oil price shocks and industry stock returns. Energy Econ 33(5):966–974

    Article  Google Scholar 

  • Engsted T, Tanggaard C (2002) The relation between asset returns and inflation at short and long horizons. J Int Financ Mark Inst Money 12(2):101–118

    Article  Google Scholar 

  • Geske R, Roll R (1983) The fiscal and monetary linkage between stock returns and inflation. J Financ 38(1):1–33

    Article  Google Scholar 

  • Gilchrist S, Leahy JV (2002) Monetary policy and asset prices. J Monet Econ 49(1):75–97

    Article  Google Scholar 

  • Godman B, Gustafsson LL (2013) A new reimbursement system for innovative pharmaceuticals combining value-based and free market pricing. Appl Health Econ Health Policy 11(1):79–82

    Article  Google Scholar 

  • Gonzalez CI, Gimeno R (2008) Financial analysts impact on stock volatility: a study on the pharmaceutical sector. fundación de estudios de economía aplicada (fedea), 1–28. FEDEA Working Paper No. 2008–19. Available at SSRN: https://ssrn.com/abstract=1132938

  • Gupta K (2016) Oil price shocks, competition, and oil and gas stock returns—global evidence. Energy Econ 57:140–153

    Article  Google Scholar 

  • Halıcı-Tülüce NS, Doğan İ, Dumrul C (2016) Is income relevant for health expenditure and economic growth nexus? Int J Health Econ Manag 16(1):23–49

    Article  Google Scholar 

  • He LT (2006) Variations in effects of monetary policy on stock market returns in the past four decades. Rev Financ Econ 15(4):331–349

    Article  Google Scholar 

  • Heidari H (2011) An alternative VAR model for forecasting iranian inflation: an application of Bewley transformation. Q Iran Econ Res 46:77–96

    Google Scholar 

  • Huang RD, Masulis RW, Stoll HR (1996) Energy shocks and financial markets. J Futures Mark 16(1):1–27

    Article  Google Scholar 

  • Iqbal J (2017) Does gold hedge stock market, inflation and exchange rate risks? An econometric investigation. Int Rev Econ Financ 48:1–17

    Article  Google Scholar 

  • Joarder MAM, Ahmed MU, Haque T, Hasanuzzaman S (2014) An empirical testing of informational efficiency in Bangladesh capital market. Econ Change Restruct 47(1):63–87

    Article  Google Scholar 

  • Jones CM, Kaul G (1996) Oil and the stock markets. J Financ 51(2):463–491

    Article  Google Scholar 

  • Kang W, Ratti RA, Yoon KH (2015) The impact of oil price shocks on the stock market return and volatility relationship. J Int Financ Mark Inst Money 34:41–54

    Article  Google Scholar 

  • Kang W, Ratti RA, Vespignani J (2016) The impact of oil price shocks on the US stock market: a note on the roles of US and non-US oil production. Econ Lett 145:176–181

    Article  Google Scholar 

  • Kang W, de Gracia FP, Ratti RA (2017) Oil price shocks, policy uncertainty, and stock returns of oil and gas corporations. J Int Money Financ 70:344–359

    Article  Google Scholar 

  • Kim S, In F (2005) The relationship between stock returns and inflation: new evidence from wavelet analysis. J Empir Financ 12(3):435–444

    Article  Google Scholar 

  • Konrad E (2009) The impact of monetary policy surprises on asset return volatility: the case of Germany. Fin Mark Portf Manag 23(2):111–135

    Article  Google Scholar 

  • Li Q, Cheng K, Yang X (2017) Response pattern of stock returns to international oil price shocks: from the perspective of China’s oil industrial chain. Appl Energy 185:1821–1831

    Article  Google Scholar 

  • Lichtenberg FR (2015) The impact of pharmaceutical innovation on premature mortality, cancer mortality, and hospitalization in Slovenia, 1997–2010. Appl Health Econ Health Policy 13(2):207–222

    Article  Google Scholar 

  • Lichtenberg FR (2016) The impact of pharmaceutical innovation on premature cancer mortality in Switzerland, 1995–2012. Eur J Health Econ 17(7):833–854

    Article  Google Scholar 

  • Malik F, Ewing BT (2009) Volatility transmission between oil prices and equity sector returns. Int Rev Financ Anal 18(3):95–100

    Article  Google Scholar 

  • Mohammadzadeh M, Rahimi F, Rahimi F, Aarabi SM, Salamzadeh J (2013) The effect of capital structure on the profitability of pharmaceutical companies the case of Iran. Iran J Pharm Res IJPR 12(3):573

    Google Scholar 

  • Nelson DB (1991) Conditional heteroskedasticity in asset returns: a new approach. Econom J Econom Soc 59:347–370

    Google Scholar 

  • Nusair SA, Al-Khasawneh JA (2017) Oil price shocks and stock market returns of the GCC countries: empirical evidence from quantile regression analysis. Econ Change Restruct. https://doi.org/10.1007/s10644-017-9207-4

    Article  Google Scholar 

  • Park K, Ratti RA (2000) Real activity, inflation, stock returns, and monetary policy. Financ Rev 35(2):59–78

    Article  Google Scholar 

  • Rasekh HR, Mehralian G, Vatankhah-Mohammadabadi AA (2012) Situation analysis of R&D activities: an empirical study in Iranian pharmaceutical companies. Iran J Pharm Res IJPR 11(4):1013

    Google Scholar 

  • Rigobon R, Sack B (2004) The impact of monetary policy on asset prices. J Monet Econ 51(8):1553–1575

    Article  Google Scholar 

  • Ruiz J (2015) Response of Spanish stock market to ECB monetary policy during financial crisis. Span Rev Financ Econ 13(2):41–47

    Article  Google Scholar 

  • Rushdi M, Kim JH, Silvapulle P (2012) ARDL bounds tests and robust inference for the long run relationship between real stock returns and inflation in Australia. Econ Model 29(3):535–543

    Article  Google Scholar 

  • Sadorsky P (1999) Oil price shocks and stock market activity. Energy Econ 21(5):449–469

    Article  Google Scholar 

  • Scholtens B, Yurtsever C (2012) Oil price shocks and European industries. Energy Econ 34(4):1187–1195

    Article  Google Scholar 

  • Sellin P (2001) Monetary policy and the stock market: theory and empirical evidence. J Econ Surv 15(4):491–541

    Article  Google Scholar 

  • Sims CA (1980) Macroeconomics and reality. Econometrica 48(1):1–48

    Article  Google Scholar 

  • Thorbecke W (1997) On stock market returns and monetary policy. J Financ 52(2):635–654

    Article  Google Scholar 

  • Tiwari AK, Dar AB, Bhanja N, Arouri M, Teulon F (2015) Stock returns and inflation in Pakistan. Econ Model 47:23–31

    Article  Google Scholar 

  • Vithessonthi C, Techarongrojwong Y (2012) The impact of monetary policy decisions on stock returns: evidence from Thailand. J Int Financ Mark Inst Money 22(3):487–507

    Article  Google Scholar 

  • Wagner S, Wakeman S (2016) What do patent-based measures tell us about product commercialization? Evidence from the pharmaceutical industry. Res Policy 45(5):1091–1102

    Article  Google Scholar 

  • Well DN (2007) Accounting for the effect of health on economic growth. Q J Econ 122(3):1265–1306

    Article  Google Scholar 

  • Zartab S, Fatemi SF, Radmanesh R (2013) Fundamentals and stock return in pharmaceutical companies: a panel data model of Iranian industry. Iran J Pharm Sci 9(1):55–60

    Google Scholar 

  • Zhou Z, Yang S (2011) How do stock return movements behave in pharmaceutical industry? A 2008–2010 study. Master thesis. Umeå School of Business

Download references

Acknowledgements

The authors would like to thank the editor and anonymous referees for their comments and suggestions have significantly improved the earlier version of this research. All remaining errors and omissions are our own responsibility.

Author information

Authors and Affiliations

  1. Department of Economics, Urmia University, P. O. Box 165, Urmia, Iran

    Hassan Heidari, Arash Refah Kahriz & Yousef Mohammadzadeh

Authors
  1. Hassan Heidari
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Arash Refah Kahriz
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Yousef Mohammadzadeh
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Yousef Mohammadzadeh.

Appendices

Appendix 1

figure a

Appendix 2

figure b

Appendix 3

See Table 6.

Table 6 Variance decompositions of other variables
Full size table

Appendix 4

See Table 7.

Table 7 Variance decompositions of other variables
Full size table

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Heidari, H., Refah Kahriz, A. & Mohammadzadeh, Y. Stock market behavior of pharmaceutical industry in Iran and macroeconomic factors. Econ Change Restruct 52, 255–277 (2019). https://doi.org/10.1007/s10644-018-9228-7

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s10644-018-9228-7

Keywords

JEL Classification

Search

Navigation